Overview
SPRY market data
Price History
SPRY price chart · 1M
- O
- 5.74
- H
- 6.09
- L
- 5.67
- C
- 6.03
- Vol
- 59,588.00
- Source
- US equities market feed
- Observed
- Aug 26, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $5.74
- Previous Close
- $5.74
- Day High
- $6.09
- Day Low
- $5.67
- 52 Week High
- $10.86
- 52 Week Low
- $5.00
- 7 Day Return
- -5.34%
- 30 Day Return
- +4.96%
- 90 Day Return
- -35.85%
- 1 Year Return
- -33.44%
- Daily Notional Volume
- $359.3K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.74 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.79 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -200.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $4.91 – $15.09 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $605.7M · P/B 10.08 · P/S 6.12.
Company News
ARS Pharmaceuticals shares are trading lower after the company reported mixed Q2 financial results.Benzinga · Aug 14, 2026, 12:40 PM
Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Moving Lower In Friday’s Pre-Market SessionBenzinga · Aug 14, 2026, 12:06 PM
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving PremarketBenzinga · Aug 14, 2026, 8:37 AM
ARS Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call TranscriptBenzinga · Aug 13, 2026, 9:17 PM
ARS Pharmaceuticals Q2 EPS $(0.63) Misses $(0.48) Estimate, Sales $33.658M Beat $31.321M EstimateBenzinga · Aug 13, 2026, 8:01 PM
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)Globenewswire Inc · Aug 6, 2026, 8:15 PM
8-K filing — ARS Pharmaceuticals, Inc. (SPRY)SEC EDGAR · Jul 17, 2026, 8:02 PM
Can ARS Pharma's New CEO Unlock Neffy's Potential?Benzinga · Jul 9, 2026, 5:40 PM
ARS Pharmaceuticals CEO Richard Lowenthal To Depart, Effective July 6; President Donn Casale Named Successor, Effective July 7Benzinga · Jul 7, 2026, 8:40 PM
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On FridayBenzinga · Jun 26, 2026, 2:25 PM